Delivery Order SPE2DB25D3201-SPE2DB25FNWPF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $21,833.56 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of PHESGO (pertuzumab, trastuzumab, and hyaluronidase) 600-600 mg in 10 ml units, totaling 20,000 units with delivery completion by October 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $5,458.39 to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 mg in 10ml vials, with a completion deadline of September 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,916.78 to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 MG in 10ML vials. This is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, issued on September 2, 2025. The contract utilizes no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work...
- The Defense Logistics Agency awarded a $10,916.78 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of PHESGO 600-600 MG pharmaceutical product (20,000 units of 10ML vials) with an ultimate completion date of October 14, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The award was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,916.78 to AmerisourceBergen Drug Corp for PHESGO 600-600 mg pharmaceutical products (20,000 units of 10ml vials). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The award was made on September 25, 2025, with an ultimate completion date of October 17, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for 20,000 units of PHESGO 600-600 MG in 10ML vials, with a contract value of $10,916.78 and completion deadline of September 17, 2025. This is a firm fixed-price delivery order issued without a set-aside designation, indicating competitive award based on the contractor's demonstrated capability to meet federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a $5,458.39 delivery order to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 MG in 10ML vials. This delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, operates under a firm fixed-price contract type with no set-aside designation. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 MG in 10ML vials, valued at $10,916.78, with a completion date of July 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the contractor's facility in...
- The Defense Logistics Agency awarded a $5,458.39 delivery order to AmerisourceBergen Drug Corp for PHESGO 600-600 mg pharmaceutical products totaling 20,000 units in 10ml formulations. This competitively awarded, firm fixed-price delivery order is expected to be completed by August 21, 2025, with performance based at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete...
- The Defense Logistics Agency awarded a delivery order valued at $10,916.78 to AmerisourceBergen Drug Corp for PHESGO 600-600 MG pharmaceutical products, with an order quantity of 20,000 units in 10ML vials. The contract is a firm fixed price delivery order with no set-aside designation, awarded on September 2, 2025, with an ultimate completion date of September 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNWPFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $21,833.56 to AmerisourceBergen Drug Corp for the supply of PHESGO (pertuzumab, trastuzumab, and hyaluronidase) 600-600 mg in 10 mL unit doses totaling 20,000 units. The contract, awarded on September 16, 2025, with an ultimate completion date of October 7, 2025, utilizes firm fixed pricing under a non-competitive delivery order structure. This order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. PHESGO is a combination therapeutic used in oncology treatment, and this procurement supports the federal government's medical supply chain requirements for military and healthcare system needs. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value through December 2026. As a major pharmaceutical distributor and established vendor for federal medical procurement, AmerisourceBergen serves as a critical supplier to the Defense Health Agency and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver specialized pharmaceutical products across multiple therapeutic domains to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.8k | 9/16/25 |